AI assistant
Gland Pharma Limited — Capital/Financing Update 2021
Feb 6, 2021
59319_rns_2021-02-06_55fe4151-33e1-4462-872e-9b871626ba98.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
==> picture [59 x 48] intentionally omitted <==
==> picture [298 x 20] intentionally omitted <==
February 6, 2021
BSE Limited National Stock Exchange of India Limited Corporate Relationship Department Listing Department Phiroze Jeejeebhoy Towers Exchange Plaza, 5th floor 25[th] floor, Dalal Street Plot no. C-1, Block G, Bandra Kurla Complex Mumbai - 400 001 Bandra (East), Mumbai - 400 051 Scrip Code: 543245 Symbol : GLAND (ISIN : INE068V01023)
Sub: Intimation of Schedule of Analyst / Institutional Investor Meetings
Dear Sir/Madam,
Pursuant to Regulation 30 read with Part A of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015, please find below the details of Investor Conferences the Company plan to attend during the month of February 2021:
| Date | Analyst/ Investor Name | Type of Meeting |
|---|---|---|
| 9-Feb-2021 | Edelweiss India Annual e-Conference2021 | Tele/Video Conference |
| 25-Feb-2021 | IIFL Securities – Global InvestorConference |
The schedule of the above mentioned meeting is subject to change and the change may occur due to exigencies on the part of Investor/ Analyst/ Company.
Yours truly,
==> picture [217 x 108] intentionally omitted <==
Factory & Regd. Office: Survey No. 143-148, 150 & 151, Near Gandimaisamma 'X' Roads, D.P. Pally, Dundigal, Dundigal-Gandimaisamma Mandal, Medchal-Malkajgiri District, Hyderabad 500043,Telangana, India Tel: +91-40-30510999 Fax; +91-40-30510800, email: [email protected] | www.glandpharma.com CIN: U24239TG1978PLC002276